Myeloid markers should be undertaken in cases of CD56 positivity to exclude granulocytic sarcoma.
Kurata
H
H
Okukubo
M
M
Fukuda
E
E
Ichihashi
M
M
Ueda
M
M
D000328:Adult; D014408:Biomarkers, Tumor / Q000032:analysis*; D019002:CD56 Antigen / Q000032:analysis*; D003937:Diagnosis, Differential; D006258:Head and Neck Neoplasms / Q000175:diagnosis*; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis; D008297:Male; D023981:Sarcoma, Myeloid / Q000175:diagnosis*; D012878:Skin Neoplasms / Q000175:diagnosis*
D014408:Biomarkers, Tumor; D019002:CD56 Antigen